Events
Register and find information for upcoming events from BioSpace and partners.
Interested in publishing your upcoming event on BioSpace? Submit events here.
Interested in putting on your own event? Talk to us.
Upcoming Events
Disease is driven by complex biological networks that remain only partially understood until experimentally resolved as a whole. Targets and compounds advance without clear biological understanding, leading to failure. AI and large-scale experimental data have scaled hypotheses and insights. The bottleneck now shifts to biological resolution.
Wednesday, May 13, 2026 11am–12pm EDT
·
Virtual
Navigating AI, Globalization, and Integration while Demonstrating Strategic Value
Monday, April 20, 2026 7:30–11:30am EDT
·
Barcelona, Spain
In this webinar, an AsymBio expert will discuss robust analytical strategies for tackling challenges in analytical method development for CQA measurement, including DAR determination, drug load distribution, free drug, and charge variant analysis.
Wednesday, April 22, 2026 10–11am EDT
·
Virtual
A premier, industry-driven forum uniting pharma, biotech, and academic leaders to advance drug discovery.
Monday, April 27, 2026 9am–5pm PDT
·
Palo Alto, CA
Work with the BioSpace Insights team to engage decision-makers through thoughtful and impactful content.
Past Events
Watch this critical discussion on how regulators and biotech companies can bridge the expectation gap during the regulatory review process to ensure novel therapies reach patients in a timely manner—because patients don’t have time to wait.
More Past Events
This webinar will help you discover effective strategies for launching your career in biotechnology. You will gain valuable insights from industry experts and leave with the essential tools you need to thrive in this dynamic field.
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
Join our webinar to explore strategies, best practices, and the evolving landscape of QARA in today’s dynamic market.
This discussion features DEIB leaders from California Life Sciences, MassBio, Eli Lilly and Takeda. We explore changing attitudes in the life sciences workforce, if organizations are adjusting either their DEIB or communication strategies, and how evolving philosophies around DEIB are impacting human resources and talent acquisition activities.
Join us in this discussion on how you can optimize your chances of landing a new role despite a highly competitive job market.